glp 1 and gip agonist The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology The Sustained Effects of a
Description
Increased FFA in the liver results in insulin resistance, hepatic glucose production, and pancreatic beta cell dysfunction [7]
OAT, organic anion transporter
doi: 10.1097/FJC.0b013e3182949673
Rapid weight loss, however, can also cause bone density loss
